These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 895858)

  • 21. Proportions of haemoglobin S in sickle-cell trait.
    Alayash AI
    Med Lab Sci; 1989 Apr; 46(2):162-3. PubMed ID: 2593776
    [No Abstract]   [Full Text] [Related]  

  • 22. Glycosylated haemoglobin HbA1c and HbS1c in non-diabetic Nigerians.
    Reid HL; Famodu AA; Photiades DP; Osamo ON
    Trop Geogr Med; 1992 Jan; 44(1-2):126-30. PubMed ID: 1496704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemoglobin S levels in sickle cell trait individuals.
    Cameron BF; Smith DB; Cody B
    Am J Hematol; 1984 Feb; 16(2):123-7. PubMed ID: 6695914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polyamines and globin binding in sickle cell disease.
    Natta CL; Motyczka AA; Kremzner LT
    Am J Pediatr Hematol Oncol; 1982; 4(1):73-6. PubMed ID: 7091579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of membrane-bound haemoglobin products in oxidative damage in sickle cell membranes.
    Rice-Evans C; Baysal E
    Acta Haematol; 1987; 78(2-3):105-8. PubMed ID: 3120454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of superoxide anion and hydrogen peroxide by erythrocytes from individuals with sickle trait or normal haemoglobin.
    Schacter LP
    Eur J Clin Invest; 1986 Jun; 16(3):204-10. PubMed ID: 3015634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minor hemoglobins in sickle-cell heterozygotes and homozygotes with and without diabetes.
    Abraham EC; Stallings M; Cameron BF; Huisman TH
    Biochim Biophys Acta; 1980 Sep; 625(1):109-17. PubMed ID: 6158340
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of cajaminose from Cajanus cajan on gelation and oxygen affinity of sickle cell haemoglobin.
    Iwu MM; Igboko AO; Onwubiko H; Ndu UE
    J Ethnopharmacol; 1988; 23(1):99-104. PubMed ID: 3419206
    [No Abstract]   [Full Text] [Related]  

  • 29. The distribution of haemoglobin S and other haemoglobin variants in a sample of Liberian paediatric subjects.
    Simbeye AG
    Biochem Exp Biol; 1978; 14(4):335-8. PubMed ID: 757517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A rare case of a compound heterozygote hemoglobin S/hemoglobin Fannin-Lubbock-I individual. Is it a sickling disorder?
    Burns NK; Risin SA
    Lab Hematol; 2010 Jun; 16(2):26-7. PubMed ID: 20534428
    [No Abstract]   [Full Text] [Related]  

  • 31. Textural differences between AA and SS blood specimens as detected by image analysis.
    Robinson RD; Benjamin LJ; Cosgriff JM; Cox C; Lapets OP; Rowley PT; Yatco E; Wheeless LL
    Cytometry; 1994 Oct; 17(2):167-72. PubMed ID: 7835167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Development of a method of screening for hemoglobin S for the purpose of genetic consultation in Cuba. Results of an analysis of 24,000 blood samples].
    Eredero L; Granda I; Al'tland K
    Genetika; 1978 Jun; 14(6):1079-84. PubMed ID: 680558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemoglobin aggregation in oxygenated sickle cells studies by carbon-13 rotating frame spin-lattice relaxation in the presence of an off-resonance radiofrequency field.
    James TL; Matthews R; Matson GB
    Biopolymers; 1979 Jul; 18(7):1763-8. PubMed ID: 540130
    [No Abstract]   [Full Text] [Related]  

  • 34. Interaction of hemoglobin Siriraj with hemoglobin S: a mild sickle cell syndrome.
    Rhoda MD; Arous N; Garel MC; Mazarin M; Monplaisir N; Braconnier F; Rosa J; Cohen-Solal M; Galacteros F
    Hemoglobin; 1986; 10(1):21-31. PubMed ID: 3754242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sickle cell-hemoglobin D Iran: benign sickle cell syndrome.
    Serjeant B; Myerscough E; Serjeant GR; Higgs DR; Moo-Penn WF
    Hemoglobin; 1982; 6(1):57-9. PubMed ID: 7073867
    [No Abstract]   [Full Text] [Related]  

  • 36. A model for the sickle cell. I. Hemorheology and II. Microcalorimetry.
    Cerny LC; Cook FB; Stasiw DM
    Biorheology; 1974 Jul; 11(4):235-9. PubMed ID: 4447819
    [No Abstract]   [Full Text] [Related]  

  • 37. Sickle solubility test to screen for sickle cell trait: what's the harm?
    Tubman VN; Field JJ
    Hematology Am Soc Hematol Educ Program; 2015; 2015():433-5. PubMed ID: 26637754
    [No Abstract]   [Full Text] [Related]  

  • 38. Protection against malaria by sickle-cell trait.
    Laser H; Klein R
    Biochem Soc Trans; 1977; 5(1):292-3. PubMed ID: 892187
    [No Abstract]   [Full Text] [Related]  

  • 39. Selected testing of newborns for sickle cell disease.
    Ohene-Frempong K
    Pediatrics; 1989 May; 83(5 Pt 2):879-80. PubMed ID: 2717319
    [No Abstract]   [Full Text] [Related]  

  • 40. Cellular mechanism for the protective effect of haemoglobin S against P. falciparum malaria.
    Pasvol G; Weatherall DJ; Wilson RJ
    Nature; 1978 Aug; 274(5672):701-3. PubMed ID: 353566
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.